Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICAF: Extended Caffeine for Intermittent Hypoxia in Preterm Infants
NCT03321734Phase 2Completed
- Sponsor
- Children's National Research Institute
- Start
- Jan 2019
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of caffeine in intermittent hypoxia (IH), sponsored by Children's National Research Institute. Started Jan 2019; status: completed.
02
Drugs
caffeine
03
Conditions
intermittent hypoxia (IH)
Beyond the preview
Go deeper on NCT03321734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03321734.